Harrow (HROW): 10% owner sold ~$150K
Opaleye Management Inc., 10% owner at Harrow, sold ~$150K of Harrow shares.
- ~$150K
- Approx. value · 5,000 sh @ $30.01
- 140K
- Holds after · shares reported
- Traded
- Mar 18, 2025
- Filed
- Mar 26, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jan 22, 2025Insider10% owner sold ~$712K of HROW shares in the open market
- Feb 28, 2025Insider10% owner sold ~$140K of HROW shares in the open market
- Mar 18, 2025 · this disclosureInsider10% owner sold ~$150K of HROW shares in the open market
What came next
- Mar 18, 2025Insider10% owner sold ~$148K of HROW shares in the open market
- Mar 24, 2025Insider10% owner sold ~$150K of HROW shares in the open market
- May 12, 2025Insider10% owner sold ~$259K of HROW shares in the open market
- May 13, 2025Insider10% owner sold ~$133K of HROW shares in the open market
- Jun 3, 2025Insider10% owner sold ~$90K of HROW shares in the open market
- Jun 4, 2025Insider10% owner sold ~$54K of HROW shares in the open market
- Jun 9, 2025Insider10% owner sold ~$462K of HROW shares in the open market
- Jun 10, 2025Insider10% owner sold ~$462K of HROW shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Harrow
For Harrow, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HROW page.
Other recent filings by Opaleye Management Inc., 10% owner
- SEC Form 4 at Grace Therapeutics (GRCE)Nov 6, 2026
- SEC Form 4 at Grace Therapeutics (GRCE)Nov 6, 2026
- SEC Form 4 at Grace Therapeutics (GRCE)Nov 6, 2026
- SEC Form 4 at Grace Therapeutics (GRCE)Oct 26, 2026
- SEC Form 4 at Alpha Cognition (ACOG)Oct 26, 2026
The full history of Opaleye Management Inc., 10% owner is on the profile page.
How this filing works
Explore the data
Other disclosures at Harrow
- SEC Form 13F-HRNov 13, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRMay 12, 2026
- SEC Form 13F-HRFeb 9, 2026
- SEC Form 13F-HRNov 14, 2025
Everything OQRO holds on this company is on its HROW page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data